Skip to content
Biodatica
Start free

Hoffmann-La Roche

Beijing, Guangdong

OncologyPhase IIIListed · RHHBY

This company trades under its own ticker, so it sits outside Biodatica’s pre-ticker window. The record stays here because its filings are real, but the feed leaves listed companies out unless you ask for them.

Compare Sign in to watch

What changed

Phase II trial registered: A Study Evaluating the Efficacy and Safety of Multiple Immunotherapy-Based Treatment Combinations in Patients With Advanced Liver Cancers (Morpheus-Liver)

3d agoTrial registeredJul 16, 2026Source filing (opens the source filing in a new tab)

Momentum

86no change

Momentum 86 out of 100, unchanged since the last recompute.

Accelerating: several high-weight events landed recently.

Runway (estimate)

—unknown

No disclosed raise on file, so there is nothing to model from.

Stage

Phase III

The furthest-along thing in the public record. Not a projection.

Runway is an estimate: the last disclosed raise (SEC Form D) minus a modeled burn rate for the company’s stage and therapeutic area. It is not a disclosure, and companies routinely raise non-dilutive money we can’t see. How this is calculated.

Grant to raise

Every record Biodatica has resolved onto this company, newest first, each linked to the filing it came from. Where a source publishes no stable deep link for a record, the identifier is shown so you can look it up yourself.

  1. Trial

    PHASE1/PHASE2 registered

    Mar 1, 2022

    Gastric and Gastroesophageal Junction Carcinoma · TERMINATED · sponsor: Hoffmann-La Roche · An Umbrella Study Evaluating the Efficacy and Safety of Multiple Treatment Combinations in Patients With Gastric or Gastroesophageal Junction Carcinoma

    ClinicalTrials.gov · NCT05251948 (opens the source filing in a new tab)

  2. Trial

    PHASE3 registered

    Dec 1, 2021

    Neoplasms · ACTIVE_NOT_RECRUITING · sponsor: Hoffmann-La Roche · An Extension Study in Participants Previously Enrolled in a Genentech and/or F. Hoffmann-La Roche Ltd Sponsored Atezolizumab Study (IMbrella C)

    ClinicalTrials.gov · NCT05112965 (opens the source filing in a new tab)

  3. Trial

    PHASE1/PHASE2 registered

    Nov 1, 2020

    Advanced Liver Cancers · RECRUITING · sponsor: Hoffmann-La Roche · A Study Evaluating the Efficacy and Safety of Multiple Immunotherapy-Based Treatment Combinations in Patients With Advanced Liver Cancers (Morpheus-Liver)

    ClinicalTrials.gov · NCT04524871 (opens the source filing in a new tab)

Biodatica publishes impersonal research shown identically to every subscriber. This dossier is informational only, it is not investment advice, and the momentum and runway figures are estimates derived from public filings. The underlying records are U.S. government works. Disclosures · Data sources